IRVINE, Calif., Feb. 15, 2017 -- Praxsyn Corporation (OTCQB: PXYN) is pleased to announce that Praxsyn’s corporate headquarters have been moved from Irvine, California to Las Vegas, Nevada.
The board of directors authorized the move of Praxsyn Corporation’s headquarters to Nevada in order to allow for the expansion of Praxsyn’s operations, the ability to secure a larger pharmacy facility in Nevada at a more competitive price, and the overall lower labor costs.
Greg Sundem, PXYN’s Chief Executive Officer, stated “I have moved to Nevada from California because I believe it is important to be physically at any new facility to oversee the day-to-day operations and to ensure a successful transition.”
The new facility provides ample space for collection operations; with our increased focus on products and services that will pay within a 30-day billing cycle. By changing the business model to a type of business that collects in a shorter amount of time, the company will have a more fiscally responsible financial model than the long collection cycle.
About Praxsyn Corporation
Headquartered in Las Vegas, Nevada, Praxsyn Corporation is a holding company that finds solutions to fit the needs and goals of medical professionals and their patients. Mesa Pharmacy, located in Irvine, California works to realize the vision of medical professionals to improve the lives of their patients. Mesa Pharmacy continues its operations and services in Irvine, California to provide patients with pharmaceutical treatments as prescribed by their doctors. Additional company information can be found at www.praxsyn.com.
Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding Praxsyn Corporation’s move to Las Vegas, Nevada, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.
###
Media/Investor Contact: [email protected] 949-777-6112 ext 101


Bill Ackman Eyes New Fund to Bet Against Market Complacency
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



